Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag

AIDS Research and Human Retroviruses

Volumn 22, Issue 5, 2006, Pages 401-410

  Cave, Eleanor ^a,b   Weinberg, Marc S ^a   Cilliers, Tonie ^b   Carmona, Sergio ^a   Morris, Lynn ^b   Arbuthnot, Patrick ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; COMPLEMENTARY DNA; GAG PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIGEN DETECTION; ARTICLE; CELL STRAIN HEK293; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS GENOME; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TYPING; WESTERN BLOTTING;

CELL LINE; GENE SILENCING; GENE TARGETING; GENES, GAG; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; VIRUS REPLICATION;

EID: 33646862794     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.401     Document Type: Article

References (39)

1. Esparza J and Bhamarapravati N: Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how? Lancet 2000;355:2061-2066.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, and Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
3. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
4. Hammond SM, Bernstein E, Beach D, and Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000;404:293-296.
5. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, and Hannon GJ: Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004;305:1437-1441.
6. Brummelkamp TR, Bernards R, and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-553.
7. Miyagishi M and Taira K: U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 2002;20:497-500.
8. Boden D, Pusch O, Silbermann R, Lee F, Tucker L, and Ramratnam B: Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004;32:1154-1158.
9. Sledz CA and Williams BR: RNA interference and double-stranded-RNA- activated pathways. Biochem Soc Trans 2004;32:952-956.
10. + progenator cell-derived macrophages. Mol Ther 2003;8:62-70.
11. Capodici J, Kariko K, and Weissman D: Inhibition of HIV-1 infection by small interfering RNA-mediated interference. J Immunol 2002;169:5196-5201.
12. Carmichael GG. Medicine: Silencing viruses with RNA. Nature 2002;418:379-380.
13. Coburn GA and Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002;76:9225-9231.
14. Jacque JM, Triques K, and Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature 2002;418:435-438.
15. Laurence J: RNA silencing: A new therapeutic strategy against HIV. AIDS Reader 2003;13:52-53.
16. Lawrence D: RNAi could hold promise in the treatment of HIV. Lancet 2002;359:2007.
17. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, and Rossi J: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-505.
18. Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE, Francois-Bongarcon V, Goldfeld A, Swamy MN, Lieberman J, and Shankar P: Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 2005;106:818-826.
19. Nelson R: Small interfering RNAs target HIV. Lancet 2003;361:2214.
20. Qin XF, An DS, Chen IS, and Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003;100:183-188.
21. Anderson J and Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005;2:1.
22. Chiu YL, Cao H, Jacque JM, Stevenson M, and Rana TM: Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol 2004;78:2517-2529.
23. Kameoka M, Nukuzuma S, Itaya A, Tanaka Y, Ota K, Ikuta K, and Yoshihara K: RNA interference directed against poly(ADP-ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J Virol 2004;78:8931-8934.
24. van Harmelen J, Williamson C, Kim B, Morris L, Carr J, Karim SS, and McCutchan F: Characterization of full-length HIV type 1 subtype C sequences from South Africa. AIDS Res Hum Retroviruses 2001;17:1527-1531.
25. Castanotto D, Li H, and Rossi JJ: Functional siRNA expression from transfected PCR products. RNA 2002;8:1454-1460.
26. Williamson C, Morris L, Maughan MF, Ping L-H, Dryga SA, Thomas R, Reap EA, Cilliers T, van Harmelen J, Pascual J, Ramjee G, Gray G, Johnston R, Abdool-Karim S, and Swanstron R: Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res Hum Retroviruses 2003;19:133-144.
27. Cilliers T, Nhlapho J, Coetzer M, Orlovic D, Ketas T, Olson W, Moore J, Trkola A, and Morris L: The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 2003;77:4449-4456.
28. Papathanasopoulos MA, Cilliers T, Morris L, Mokili JL, Dowling W, Birx DL, and McCutchan FE: Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS Res Hum Retroviruses 2002;18:879-886.
29. Passman M, Weinberg M, Kew M, and Arbuthnot P: In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem Biophys Res Commun 2000;268:728-733.
30. Wang C and Stiles CD: Platelet-derived growth factor a receptor gene expression: Isolation and characterization of the promoter and upstream regulatory elements. Proc Natl Acad Sci USA 1994;91:7061-7065.
31. Sanes JR, Rubenstein JL, and Nicolas JF: Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986;5:3133-3142.
32. Rekhviashvili N, Stevens G, Scott L, and Stevens W: Fluorogeni-cLUX primer for quantitation of HIV-1 by real-time RT-PCR. Mol Biotechnol 2006;32:101-110.
33. Sen GC and Sarkar SN: Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 2005;16:1-14.
34. Khvorova A, Reynolds A, and Jayasena D: Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115:209-216.
35. Boden D, Pusch O, Silbermann R, Lee F, Tucker L, and Ramratnam B: Human immunodeficiency virus type 1 escape from RNA Interference. J Virol 2003;77:11531-11535.
36. Amarzguioui M, Holen T, Babaie E, and Prydz H: Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 2003;31:589-595.
37. Westerhout EM, Ooms M, Vink M, Das AT, and Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005;33:796-804.
38. Pusch O, Boden D, Silbermann R, Lee F, Tucker L, and Ramratnam B: Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res 2003;31:6444-6449.
39. Hannon GJ and Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-378.